[ad_1]
New study: 5 years of treatment with acetylsalicylic acid reduce the risk of death from cancer
A five-year treatment with low-dose acetylsalicylic acid (ASA) reduces the risk of death in several common cancers, such as brain, lung, pancreatic and prostate tumors, according to new findings . The benefit of treatment is to consider the risk of bleeding, according to The Lancet researchers after reviewing data from several scientific studies.
They feel that a preventive treatment of ASA would be more cost effective than, for example, mammography and routine PSA testing.
A few weeks ago, a study showed that ASA protects against colon cancer. According to the results presented, based on the results of more than 25,500 people, the ASA reduces the risk of death from prostate cancer by 10% over a period of 20 years. The protective effect appeared previously for cancer of the esophagus, pancreas, brain and lungs.
analgesic
ASA is one of the most used drugs in the world. It has analgesic, anti-inflammatory, anti-fever properties and belongs to the group of nonsteroidal anti-inflammatory drugs (NSAIDs). As ASA reduces the blood's ability to live, current medicine is used to fight heart attacks and strokes in people at high risk of suffering.
The disadvantages of ASA are that the drugs irritate the lining of the stomach and can cause gastric ulcers. In addition, ASA can mask the signs of an infection.
TT
Source link
